Actualités Repligen Corp - RGEN | Actions NASDAQ | ADVFN

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Repligen Corp (RGEN)

146,06

3,48

(2,44%)

À la fermeture: 25 Novembre 10:00PM

Retardé de 15 minutes

146,06

-0,16

( -0,11% )

Après les heures de négociation: 10:20PM

Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Repligen Reports Third Quarter 2024 Financial Results

Third quarter reported revenue of $155 million, an increase of 10% year-over-yearCDMO revenue and orders both...

Repligen Corporation to Present at Upcoming Investor Conferences

WALTHAM, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales